# EMBEDA
> **NDA022321** · New Drug Application · Sponsor: ALPHARMA PHARMS · Approved 2009-08-13
## Drug
- **FDA Application Number:** NDA022321
- **Application type:** New Drug Application
- **Brand name:** EMBEDA
- **Generic name:** Morphine Sulfate
- **Active ingredients:** MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ALPHARMA PHARMS
- **First approval:** 2009-08-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022321)
---
*MORVS · CC0 1.0*